The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors

Summary

This study is an open-label, phase I clinical trial of SHR-7631 in patients with advanced solid tumors. The whole study is divided into three stages: dose escalation, dose expansion and efficacy expansion.

Timeline

Start

2024-05-24

Primary completion

2025-03-21

Completion

2025-03-21

Drugs

Indications